Evidence map›Paper›PMID 36571262›Full record

ArticleJournal of medical virology2023

Cryptic resolution sites in the vector plasmid lead to the heterogeneities in the rAAV vectors.

Junping Zhang, Matthew Chrzanowski, Dylan A Frabutt, Anh K Lam, Patrick L Mulcrone, Lei Li, Barbara A Konkle, Carol H Miao, Weidong Xiao

Open access · greenAbstract read
In one paragraph

Article in Journal of medical virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Junping ZhangHerman B Wells Center for Pediatric Research, Indiana University, Indianapolis, Indiana, USA.ORCID 0000-0001-9566-3875
Matthew ChrzanowskiLewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
Dylan A FrabuttHerman B Wells Center for Pediatric Research, Indiana University, Indianapolis, Indiana, USA.
Anh K LamHerman B Wells Center for Pediatric Research, Indiana University, Indianapolis, Indiana, USA.
Patrick L MulcroneHerman B Wells Center for Pediatric Research, Indiana University, Indianapolis, Indiana, USA.
Lei LiDepartment of Chemistry, Georgia State University, Atlanta, Georgia, USA.
Barbara A KonkleBloodworks Northwest, Seattle, Washington, USA.
Carol H MiaoCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, Washington, USA.
Weidong XiaoHerman B Wells Center for Pediatric Research, Indiana University, Indianapolis, Indiana, USA.
Indiana University – Purdue University Indianapolis · USBloodworks Northwest · USGeorgia State University · USSeattle Children's Hospital · USTemple University · US

Funding

Toward Safer Gene Therapy for Hemophilia AP01HL160472 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI Roland W. Herzog · 2022 to 2026
$15.1M
BASIC SCIENCE STUDIES ON GENE THERAPY OF BLOOD DISEASEST32HL007910 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Roland W. Herzog, Reuben Kapur · 1999 to 2026
$7.6M
Temple Project 1: Genetic characterization of factor VIII Inhibitors and glydosylation patternsU54HL142019 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI LI, LEI, MIAO, CAROL H · 2018 to 2022
$6.9M
Intraosseous delivery of lentiviral vectors for hemophilia A gene therapyR01HL134321 · NHLBI · SEATTLE CHILDREN'S HOSPITAL · PI Carol H Miao · 2016 to 2026
$6.2M
Novel adeno-associated virus vector production system developmentR01HL114152 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI XIAO, WEIDONG · 2012 to 2016
$2.2M
NHLBI NIH HHS P01 HL160472NHLBI NIH HHS R01 HL114152NHLBI NIH HHS R01 HL134321NHLBI NIH HHS T32 HL007910NHLBI NIH HHS U54 HL142019NIH HHS
6 · The paper itself

Abstract

Recombinant adeno-associated virus (rAAV) vectors carry a cassette of interest retaining only the inverted terminal repeats (ITRs) from the wild-type virus. Conventional rAAV production primarily uses a vector plasmid as well as helper genes essential for AAV replication and packaging. Nevertheless, plasmid backbone related contaminants have been a major source of vector heterogeneity. The mechanism driving the contamination phenomenon has yet to be elucidated. Here we identified cryptic resolution sites in the plasmid backbone as a key source for producing snapback genomes, which leads to the increase of vector genome heterogeneity in encapsidated virions. By using a single ITR plasmid as a model molecule and mapping subgenomic particles, we found that there exist a few typical DNA break hotspots in the vector DNA plasmid backbone, for example, on the ampicillin DNA element, called aberrant rescue sites. DNA around these specific breakage sites may assume some typical secondary structures. Similar to normal AAV vectors, plasmid DNA with a single ITR was able to rescue and replicate efficiently. These subgenomic DNA species significantly compete for trans factors required for rAAV rescue, replication, and packaging. The replication of single ITR contaminants during AAV production is independent of size. Packaging of these species is greatly affected by its size. A single ITR and a cryptic resolution site in the plasmid work synergistically, likely causing a source of plasmid backbone contamination.

Indexed as

DNA, ViralGenetic VectorsDependovirusHumansPlasmidsDNA, Viralcryptic resolutionheterogeneityrAAVsingle ITR

Identifiers

PMID36571262
PMCPMC10155192
OpenAlexW4312195721

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.